The effect of body mass index on fasting blood glucose after initiation of thiazide therapy in hypertensive patients

David Siegel, Joy Meier, Crystal Maas, Julio Lopez, Arthur L Swislocki

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Background: The prevalence of obesity, hypertension, and type 2 diabetes mellitus is increasing in the United States. In this setting, it is important to understand the effects of antihypertensives on glucose metabolism. We therefore examined the association between body mass index (BMI) (kg/m2) and fasting blood glucose (FBG) in subjects in whom thiazide antihypertensive therapy had been initiated. Methods: A retrospective observational study was carried out on individuals with hypertension who had been started on thiazide therapy. The subjects' age, thiazide dose, BMI, serum potassium, FBG, new onset of diabetes mellitus, and concurrent use of other antihypertensives were included in the analysis. Predictors of change in FBG were analyzed using multiple linear regression analysis, while predictors of new-onset diabetes mellitus were determined using multiple logistic regression. Results: A total of 2,624 individuals who had been started on thiazide therapy for hypertension were divided into quartiles of increasing BMI. FBG was found to be associated with baseline BMI and, after thiazide initiation, there was a step-wise increase in the magnitude of change in FBG with increasing BMI (P < 0.001 for both). Analysis using multiple linear regression found that BMI and baseline FBG predicted the magnitude of FBG change in subjects initiated on thiazide treatment (P < 0.001 for both). Analysis with logistic regression found that, after thiazide initiation, BMI, serum potassium baseline (P < 0.05 for both), and baseline FBG (P < 0.001) predicted the development of diabetes mellitus. Conclusions: There is an overall increase in FBG in individuals who are started on treatment with thiazides for hypertension. The magnitude of change in FBG and the development of new-onset diabetes mellitus after thiazide initiation were associated with increases in BMI and baseline FBG.

Original languageEnglish (US)
Pages (from-to)438-442
Number of pages5
JournalAmerican Journal of Hypertension
Volume21
Issue number4
DOIs
StatePublished - Apr 2008

Fingerprint

Thiazides
Blood Glucose
Fasting
Body Mass Index
Diabetes Mellitus
Therapeutics
Antihypertensive Agents
Hypertension
Linear Models
Potassium
Logistic Models
Serum
Type 2 Diabetes Mellitus
Observational Studies
Retrospective Studies
Obesity

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

The effect of body mass index on fasting blood glucose after initiation of thiazide therapy in hypertensive patients. / Siegel, David; Meier, Joy; Maas, Crystal; Lopez, Julio; Swislocki, Arthur L.

In: American Journal of Hypertension, Vol. 21, No. 4, 04.2008, p. 438-442.

Research output: Contribution to journalArticle

@article{f37be8b012d1406c994565dbeaad84ea,
title = "The effect of body mass index on fasting blood glucose after initiation of thiazide therapy in hypertensive patients",
abstract = "Background: The prevalence of obesity, hypertension, and type 2 diabetes mellitus is increasing in the United States. In this setting, it is important to understand the effects of antihypertensives on glucose metabolism. We therefore examined the association between body mass index (BMI) (kg/m2) and fasting blood glucose (FBG) in subjects in whom thiazide antihypertensive therapy had been initiated. Methods: A retrospective observational study was carried out on individuals with hypertension who had been started on thiazide therapy. The subjects' age, thiazide dose, BMI, serum potassium, FBG, new onset of diabetes mellitus, and concurrent use of other antihypertensives were included in the analysis. Predictors of change in FBG were analyzed using multiple linear regression analysis, while predictors of new-onset diabetes mellitus were determined using multiple logistic regression. Results: A total of 2,624 individuals who had been started on thiazide therapy for hypertension were divided into quartiles of increasing BMI. FBG was found to be associated with baseline BMI and, after thiazide initiation, there was a step-wise increase in the magnitude of change in FBG with increasing BMI (P < 0.001 for both). Analysis using multiple linear regression found that BMI and baseline FBG predicted the magnitude of FBG change in subjects initiated on thiazide treatment (P < 0.001 for both). Analysis with logistic regression found that, after thiazide initiation, BMI, serum potassium baseline (P < 0.05 for both), and baseline FBG (P < 0.001) predicted the development of diabetes mellitus. Conclusions: There is an overall increase in FBG in individuals who are started on treatment with thiazides for hypertension. The magnitude of change in FBG and the development of new-onset diabetes mellitus after thiazide initiation were associated with increases in BMI and baseline FBG.",
author = "David Siegel and Joy Meier and Crystal Maas and Julio Lopez and Swislocki, {Arthur L}",
year = "2008",
month = "4",
doi = "10.1038/ajh.2007.75",
language = "English (US)",
volume = "21",
pages = "438--442",
journal = "American Journal of Hypertension",
issn = "0895-7061",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - The effect of body mass index on fasting blood glucose after initiation of thiazide therapy in hypertensive patients

AU - Siegel, David

AU - Meier, Joy

AU - Maas, Crystal

AU - Lopez, Julio

AU - Swislocki, Arthur L

PY - 2008/4

Y1 - 2008/4

N2 - Background: The prevalence of obesity, hypertension, and type 2 diabetes mellitus is increasing in the United States. In this setting, it is important to understand the effects of antihypertensives on glucose metabolism. We therefore examined the association between body mass index (BMI) (kg/m2) and fasting blood glucose (FBG) in subjects in whom thiazide antihypertensive therapy had been initiated. Methods: A retrospective observational study was carried out on individuals with hypertension who had been started on thiazide therapy. The subjects' age, thiazide dose, BMI, serum potassium, FBG, new onset of diabetes mellitus, and concurrent use of other antihypertensives were included in the analysis. Predictors of change in FBG were analyzed using multiple linear regression analysis, while predictors of new-onset diabetes mellitus were determined using multiple logistic regression. Results: A total of 2,624 individuals who had been started on thiazide therapy for hypertension were divided into quartiles of increasing BMI. FBG was found to be associated with baseline BMI and, after thiazide initiation, there was a step-wise increase in the magnitude of change in FBG with increasing BMI (P < 0.001 for both). Analysis using multiple linear regression found that BMI and baseline FBG predicted the magnitude of FBG change in subjects initiated on thiazide treatment (P < 0.001 for both). Analysis with logistic regression found that, after thiazide initiation, BMI, serum potassium baseline (P < 0.05 for both), and baseline FBG (P < 0.001) predicted the development of diabetes mellitus. Conclusions: There is an overall increase in FBG in individuals who are started on treatment with thiazides for hypertension. The magnitude of change in FBG and the development of new-onset diabetes mellitus after thiazide initiation were associated with increases in BMI and baseline FBG.

AB - Background: The prevalence of obesity, hypertension, and type 2 diabetes mellitus is increasing in the United States. In this setting, it is important to understand the effects of antihypertensives on glucose metabolism. We therefore examined the association between body mass index (BMI) (kg/m2) and fasting blood glucose (FBG) in subjects in whom thiazide antihypertensive therapy had been initiated. Methods: A retrospective observational study was carried out on individuals with hypertension who had been started on thiazide therapy. The subjects' age, thiazide dose, BMI, serum potassium, FBG, new onset of diabetes mellitus, and concurrent use of other antihypertensives were included in the analysis. Predictors of change in FBG were analyzed using multiple linear regression analysis, while predictors of new-onset diabetes mellitus were determined using multiple logistic regression. Results: A total of 2,624 individuals who had been started on thiazide therapy for hypertension were divided into quartiles of increasing BMI. FBG was found to be associated with baseline BMI and, after thiazide initiation, there was a step-wise increase in the magnitude of change in FBG with increasing BMI (P < 0.001 for both). Analysis using multiple linear regression found that BMI and baseline FBG predicted the magnitude of FBG change in subjects initiated on thiazide treatment (P < 0.001 for both). Analysis with logistic regression found that, after thiazide initiation, BMI, serum potassium baseline (P < 0.05 for both), and baseline FBG (P < 0.001) predicted the development of diabetes mellitus. Conclusions: There is an overall increase in FBG in individuals who are started on treatment with thiazides for hypertension. The magnitude of change in FBG and the development of new-onset diabetes mellitus after thiazide initiation were associated with increases in BMI and baseline FBG.

UR - http://www.scopus.com/inward/record.url?scp=41349095069&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41349095069&partnerID=8YFLogxK

U2 - 10.1038/ajh.2007.75

DO - 10.1038/ajh.2007.75

M3 - Article

C2 - 18246056

AN - SCOPUS:41349095069

VL - 21

SP - 438

EP - 442

JO - American Journal of Hypertension

JF - American Journal of Hypertension

SN - 0895-7061

IS - 4

ER -